Hans van der Vliet, PhD, MDChief Scientific Officer at Lava Therapeutics BV
Profile
Hans van der Vliet, MD PhD is a medical oncologist and associate professor at the department of medical oncology of the Amsterdam UMC, VU University and Cancer Center Amsterdam and scientific founder and CSO of Lava Therapeutics B.V., a biotech company that develops proprietary Vγ9Vδ2 T-cell engagers.
Agenda Sessions
Bispecific T cell Engagers
9:45amView SessionBispecific γδ-T cell Engagers for Cancer Immunotherapy
On DemandView Session